Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROTECTOR 1: RTB101 for prevention of respiratory illness in the elderly
NCT04668352Phase 3Completed
- Sponsor
- resTORbio
- Start
- Apr 2019
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dactolisib in respiratory tract infection (RTI), sponsored by resTORbio. Started Apr 2019; status: completed.
02
Drugs
dactolisib
03
Conditions
respiratory tract infection (RTI)
Beyond the preview
Go deeper on NCT04668352.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04668352.